pubmed-article:15771429 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0020205 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0002302 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0017048 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C1417061 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C1417063 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0181586 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0599740 | lld:lifeskim |
pubmed-article:15771429 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:15771429 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15771429 | pubmed:dateCreated | 2005-3-17 | lld:pubmed |
pubmed-article:15771429 | pubmed:abstractText | To further evaluate elements that could contribute to the 3D topographical structure of gamma-MSH, we have systematically designed a group of linear gamma-MSH analogues and evaluated their biological activities: without a N-terminal acetyl, with and without a C-terminal amide, with Nle(3), with l- or d-Phe(6) or d-Nal(2')(6), and with d-Trp(8) or d-Nal(2')(8). It was found that changing the C-terminal acid in gamma-MSH to an amide and replacing Met with Nle leads to increased binding affinities at all four subtypes of melanocortin receptors (10-100 fold). Substitution of Trp(8) with d-Nal(2')(8) and Phe(6) with d-Phe(6) in gamma-MSH-NH(2) forms a selective antagonist for the hMC3R, whereas, substitution of Phe(6) with d-Nal(2')(6) and replacing Trp(8) with d-Trp(8) at gamma-MSH-NH(2) yields a selective partial agonist for the hMC1R. Finally, substitution of His(5) with Pro(5) and Trp(8) with d-Nal(2')(8) in gamma-MSH-NH(2) leads to a highly potent and selective agonist for the hMC1R. Molecular modeling showed that, at the C-terminal of Nle(3)-gamma-MSH-NH(2), there is a reverse-turn-like structure, suggesting that there might be a secondary binding site involved in ligand-receptor interaction for gamma-MSH analogues that may explain the enhanced binding affinities of the Nle(3)-gamma-MSH-NH(2) analogues. Our results indicate that increasing the hydrophobicity and replacing Phe(6) and Trp(8) with bulkier aromatic amino acid residues is very important for selectivity of alpha-MSH/gamma-MSH hybrids for hMCRs. | lld:pubmed |
pubmed-article:15771429 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:language | eng | lld:pubmed |
pubmed-article:15771429 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15771429 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15771429 | pubmed:month | Mar | lld:pubmed |
pubmed-article:15771429 | pubmed:issn | 0022-2623 | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:HrubyVictor... | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:TrivediDevD | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:CaiMinyingM | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:CabelloChrist... | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:StankovaMagda... | lld:pubmed |
pubmed-article:15771429 | pubmed:author | pubmed-author:MayorovAlexan... | lld:pubmed |
pubmed-article:15771429 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15771429 | pubmed:day | 24 | lld:pubmed |
pubmed-article:15771429 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:15771429 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15771429 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15771429 | pubmed:pagination | 1839-48 | lld:pubmed |
pubmed-article:15771429 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:meshHeading | pubmed-meshheading:15771429... | lld:pubmed |
pubmed-article:15771429 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15771429 | pubmed:articleTitle | Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues. | lld:pubmed |
pubmed-article:15771429 | pubmed:affiliation | Department of Chemistry, University of Arizona, Tucson, Arizona 85721, USA. | lld:pubmed |
pubmed-article:15771429 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15771429 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:15771429 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15771429 | lld:pubmed |